Porous SiO2/MgF2 broadband antireflection coatings for superstrate-type silicon-based tandem cells.

The purpose of this study is to reduce the glass substrate reflectivity over a wide spectral range (400-1200 nm) without having high reflectivity in the near-infrared region. After making porous SiO2/MgF2 double-layer antireflection (DLAR) thin film structure, the superstrate-type silicon-based tandem cells are added. In comparison to having only silicon-based tandem solar cells, the short-circuit current density has improved by 6.82% when porous SiO2/MgF2 DLAR thin film is applied to silicon-based tandem solar cells. This study has demonstrated that porous SiO2/MgF2 DLAR thin film structure provides antireflection properties over a broad spectral range (400-1200 nm) without having high reflectivity at near-infrared wavelengths.

More than 10 years experience of beam monitoring with the Gantry 1 spot scanning proton therapy facility at PSI.

PURPOSE: The beam monitoring equipments developed for the first PSI spot scanning proton therapy facility, Gantry 1, have been successfully used for more than 10 years. The purpose of this article is to summarize the author's experience in the beam monitoring technique for dynamic proton scanning. METHODS: The spot dose delivery and verification use two independent beam monitoring and computer systems. In this article, the detector construction, electronic system, dosimetry, and quality assurance results are described in detail. The beam flux monitor is calibrated with a Faraday cup. The beam position monitoring is realized by measuring the magnetic fields of deflection magnets with Hall probes before applying the spot and by checking the beam position and width with an ionization strip chamber after the spot delivery. RESULTS: The results of thimble ionization chamber dosimetry measurements are reproducible (with a mean deviation of less than 1% and a standard deviation of 1%). The resolution in the beam position measurement is of the order of a tenth of a millimeter. The tolerance of the beam position delivery and monitoring during scanning is less than 1.5 mm. CONCLUSIONS: The experiences gained with the successful operation of Gantry 1 represent a unique and solid background for the development of a new system, Gantry 2, in order to perform new advanced scanning techniques.

Treatment planning and verification of proton therapy using spot scanning: initial experiences.

Since the end of 1996, we have treated more than 160 patients at PSI using spot-scanned protons. The range of indications treated has been quite wide and includes, in the head region, base-of-skull sarcomas, low-grade gliomas, meningiomas, and para-nasal sinus tumors. In addition, we have treated bone sarcomas in the neck and trunk--mainly in the sacral area--as well as prostate cases and some soft tissue sarcomas. PTV volumes for our treated cases are in the range 20-4500 ml, indicating the flexibility of the spot scanning system for treating lesions of all types and sizes. The number of fields per applied plan ranges from between 1 and 4, with a mean of just under 3 beams per plan, and the number of fluence modulated Bragg peaks delivered per field has ranged from 200 to 45 000. With the current delivery rate of roughly 3000 Bragg peaks per minute, this translates into delivery times per field of between a few seconds to 20-25 min. Bragg peak weight analysis of these spots has shown that over all fields, only about 10% of delivered spots have a weight of more than 10% of the maximum in any given field, indicating that there is some scope for optimizing the number of spots delivered per field. Field specific dosimetry shows that these treatments can be delivered accurately and precisely to within +/-1 mm (1 SD) orthogonal to the field direction and to within 1.5 mm in range. With our current delivery system the mean widths of delivered pencil beams at the Bragg peak is about 8 mm (sigma) for all energies, indicating that this is an area where some improvements can be made. In addition, an analysis of the spot weights and energies of individual Bragg peaks shows a relatively broad spread of low and high weighted Bragg peaks over all energy steps, indicating that there is at best only a limited relationship between pencil beam weighting and depth of penetration. This latter observation may have some consequences when considering strategies for fast re-scanning on second generation scanning gantries.

Development of an inorganic scintillating mixture for proton beam verification dosimetry.

The availability at the Paul Scherrer Institute (PSI) of a spot-scanning technique with an isocentric beam delivery system (gantry) allows the realization of intensity-modulated proton therapy (IMPT). The development of 3D dosimetry is an important tool for the verification of IMPT therapy plans based on inhomogeneous 3D conformal dose distributions. For that purpose new dosimeters are being developed. The concept is to use a system of many millimetre sized scintillating volumes distributed in a polyethylene block, which are read on a CCD camera over a bundle of optical fibres and which can be irradiated from any direction orthogonal to the fibre axis. The purpose of this work is to investigate the composition of such small sensitive volumes. A mixture of inorganic phosphors and optical cement allows an optimal coupling between the scintillating volume and the optical fibre. Five different inorganic phosphors, available as powder, have been examined by considering their response along the Bragg curve. In particular, two phosphors have shown interesting behaviours: Gd2O2S:Tb and (Zn, Cd)S:Ag. Both phosphors have a high emission efficiency but contrasting behaviour in the Bragg peak region. The efficiency of Gd2O2S:Tb decreases with increasing stopping power (quenching of luminescence) while that of (Zn, Cd)S:Ag increases. Because of these contrasting behaviours it is possible to prepare a mixture of the two scintillating powders in a certain ratio in order to modulate the height of the measured Bragg peak relative to the entrance value so that it is in agreement with the ionization chamber measurements. We propose to use a mixture for the sensitive volume consisting of the following weight fractions: 48% Gd2O2S:Tb, 12% (Zn, Cd)S:Ag and 40% optical cement.

The PSI Gantry 2: a second generation proton scanning gantry.

PSI is still the only location in which proton therapy is applied using a dynamic beam scanning technique on a very compact gantry. Recently, this system is also being used for the application of intensity-modulated proton therapy (IMPT). This novel technical development and the success of the proton therapy project altogether have led PSI in Year 2000 to further expand the activities in this field by launching the project PROSCAN. The first step is the installation of a dedicated commercial superconducting cyclotron of a novel type. The second step is the development of a new gantry, Gantry 2. For Gantry 2 we have chosen an iso-centric compact gantry layout. The diameter of the gantry is limited to 7.5 m, less than in other gantry systems (approximately 10-12 m). The space in the treatment room is comfortably large, and the access on a fixed floor is possible any time around the patient table. Through the availability of a faster scanning system, it will be possible to treat the target volume repeatedly in the same session. For this purpose, the dynamic control of the beam intensity at the ion source and the dynamic variation of the beam energy will be used directly for the shaping of the dose.